The Architect Of Biogen's Controversial Alzheimer's Strategy, Al Sandrock, To Retire

 
• By Jessica Merrill and Alaric DeArment
  
Biogen
Biogen's Al Sandrock is retiring • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Leadership

More from Scrip